Clinical Trial

Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Cesarean section is one of the most commonly performed surgical procedures worldwide, making effective management of acute postoperative pain a key issue in obstetric anesthesiology. Post-cesarean analgesia should promote rapid maternal recovery, support newborn care, and consider the pharmacological implications for breastfeeding. According to recent PROSPECT® guidelines from ESRA, neuraxial opioids play a central role in post-cesarean analgesia and are at least as effective as other techniques, such as continuous local anesthetic infusion. However, the optimal route of opioid administration remains unclear. While earlier studies favored epidural morphine, more recent evidence suggests that intrathecal morphine may provide superior analgesia. Due to limited and conflicting data, no definitive conclusion can be drawn. Given that epidural morphine remains standard practice at Hospital Central do Funchal, a randomized clinical trial is proposed to compare the analgesic efficacy of intrathecal versus epidural morphine after elective cesarean section.
Trial Details
NCT Number NCT07386353
Lead Sponsor Hospital Central do Funchal
Conditions Analgesia Obstetrical, Analgesia, Post Operative Pain, Patient Satisfaction, Cesarean Section Pain
Enrollment 120 participants
Start Date 2024-05-20
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-04